COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring bla_IND-2, bla_CIA and bla_CcrA

Ting-Kuang Yeh1 Division of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan

https://orcid.org/0000-0001-5540-4780 View further author information

Zong-Hao Li2 Department of Computer Science and Information Engineering, National Chung Cheng University, Chiayi, Taiwan

https://orcid.org/0000-0003-2235-6131 View further author information

Yao-Ting Huang2 Department of Computer Science and Information Engineering, National Chung Cheng University, Chiayi, TaiwanView further author information

Po-Yu Liu1 Division of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan;3 Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan;4 Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, TaiwanCorrespondence[email protected]

https://orcid.org/0000-0001-8006-4917 View further author information

References

Vijay S, Bansal N, Rao BK, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893–1903. doi:10.2147/IDR.S299774
PubMed Web of Science ®Google Scholar
Ukuhor HO. The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics. J Infect Public Health. 2021;14(1):53–60. doi:10.1016/j.jiph.2020.10.018
PubMed Web of Science ®Google Scholar
Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018;67(12):1803–1814. doi:10.1093/cid/ciy378
PubMed Web of Science ®Google Scholar
Mukerji R, Kakarala R, Smith SJ, Kusz HG. Chryseobacterium indologenes: an emerging infection in the USA. BMJ Case Rep. 2016;2016. doi:10.1136/bcr-2016-214486
PubMedGoogle Scholar
Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). J Clin Microbiol. 2004;42(1):445–448. doi:10.1128/JCM.42.1.445-448.2004
Web of Science ®Google Scholar
Zhang Y, Li D, Yang Y, et al. Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China. Ann Transl Med. 2021;9(8):668. doi:10.21037/atm-21-933
Web of Science ®Google Scholar
Rasmussen BA, Gluzman Y, Tally FP. Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother. 1990;34(8):1590–1592. doi:10.1128/AAC.34.8.1590
Web of Science ®Google Scholar

COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring bla_IND-2, bla_CIA and bla_CcrA

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring blaIND-2, blaCIA and blaCcrA

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring bla_IND-2, bla_CIA and bla_CcrA